Syngene International Ltd

The company's financial performance and growth profile has weakened considerably. While historical growth was robust, recent trends indicate a sharp deceleration. Compounded sales growth has slowed from a 5-year average of 11% to just 3% on a TTM basis. The decline is more pronounced in profitability, where the 3-year compounded profit growth is negative, and the TTM figure shows a significant contraction. Quarterly results reinforce this trend, with YOY sales growth turning negative in some recent periods and profit growth showing high volatility. Although annual operating margins have remained stable and strong at around 29%, the top-line and bottom-line growth erosion is a primary concern. The inconsistency of earnings, particularly in recent quarters, points to increasing business volatility.

Capital efficiency and returns present a deteriorating picture. The Return on Equity (ROE) has shown a clear declining trend, falling from a 3-year average of 10% to just 8% in the last year, indicating that shareholder funds are generating lower returns. Similarly, the Cash Conversion Cycle (CCC), a key indicator of working capital management, has worsened dramatically. After maintaining an excellent negative CCC a few years ago, it turned positive and rose to 92 days in FY23 before a partial recovery to 40 days in FY24. This shift signifies less efficient management of working capital. While the Return on Capital Employed (ROCE) has stagnated in the 14-15% range, the declining ROE and worsened CCC point to lower overall efficiency.

The company exhibits excellent financial health and prudence. Management has effectively controlled leverage, as evidenced by a consistently low and decreasing debt profile. The Debt-to-Equity ratio stood at a very healthy 0.13 in March 2024, down from 0.31 in March 2022, indicating a strong balance sheet with minimal reliance on external debt. This conservative approach to financing provides a solid buffer against financial stress. Furthermore, the company's ability to service its interest obligations is outstanding. The interest coverage ratio was a robust 21.6x in FY24, showing that operating profits cover interest expenses many times over. The dividend payout has also been consistent over the last three years at around 10-11%.

The shareholding structure has undergone significant changes that signal wavering confidence from key stakeholders. The most notable event is the substantial reduction in promoter holding, which dropped from 70.41% in March 2022 to 54.88% by March 2023. While the current holding of 54.79% is still a majority, such a large divestment is a significant negative signal. Concurrently, Foreign Institutional Investors (FIIs), after absorbing the promoter's sale, have been reducing their stake, which fell from 23.31% in March 2023 to 20.92% in March 2024. While this selling pressure has been absorbed by a strong and steady increase in Domestic Institutional Investor (DII) holding, the combined signal from promoters and FIIs is a concern.

A notable risk indicator is the significant increase in Capital Work in Progress (CWIP). The CWIP balance surged from ₹177 Cr in March 2023 to ₹838 Cr in March 2024, a 373% increase. This represents a substantial investment in assets that are not yet generating revenue. This aggressive capex cycle coincides with a period of slowing sales and profit growth. This disconnect poses a risk: if the anticipated demand for which this capacity is being built does not materialize, the company could face issues with asset underutilization, higher depreciation charges without corresponding revenue, and a decline in overall capital efficiency metrics like ROCE.